Genomic and molecular analyses identify molecular subtypes of pancreatic cancer recurrence

Dreyer, S. B., Upstill-Goddard, R., Legrini, A., Biankin, A. V. , Jamieson, N. B. and Chang, D. K. (2022) Genomic and molecular analyses identify molecular subtypes of pancreatic cancer recurrence. Gastroenterology, 162(1), 320-324.e4. (doi: 10.1053/j.gastro.2021.09.022) (PMID:34534536) (PMCID:PMC8721486)

[img] Text
252077.pdf - Published Version
Available under License Creative Commons Attribution.

2MB

Abstract

No abstract available.

Item Type:Articles
Additional Information:Research Funding Support: • Cancer Research UK Postdoctoral research bursary: C54177/A30322 • Wellcome Trust Senior Investigator Award: 103721/Z/14/Z • Cancer Research UK Programme: C29717/A17263 and C29717/A18484 • Cancer Research UK Glasgow Centre: C596/A18076 • Cancer Research UK Clinical Training Award: C596/A20921 • Cancer Research UK Clinician Scientist Award: C55370/A25813 • The National Health & Medical Research Council of Australia, The Cancer Council NSW, Cancer Institute NSW, Royal Australasian College of Surgeons, St Vincent’s Clinic Foundation and R. T. Hall Trust. • The Avner Pancreatic Cancer Foundation
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Jamieson, Professor Nigel and Chang, Professor David and Dreyer, Dr Stephan and Upstill-Goddard, Dr Rosie and Biankin, Professor Andrew and legrini, assya
Authors: Dreyer, S. B., Upstill-Goddard, R., Legrini, A., Biankin, A. V., Jamieson, N. B., and Chang, D. K.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Gastroenterology
Publisher:Elsevier
ISSN:0016-5085
ISSN (Online):1528-0012
Published Online:14 September 2021
Copyright Holders:Copyright © 2021 AGA Institute
First Published:First published in Gastroenterology 162(1): 320-324.e4
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
309422Characterising the immune landscape of molecular subtypes of pancreatic ductal adenocarcinomaStephan DreyerCancer Research UK (CRUK)C54177/A30322Institute of Cancer Sciences
170634Defining Platinum and PARP Responsive Molecular Phenotypes of Pancreatic Cancer.Andrew BiankinWellcome Trust (WELLCOTR)103721/Z/14/ZInstitute of Cancer Sciences
169396Genotype Guided Stratified Therapy for Pancreatic CancerAndrew BiankinCancer Research UK (CRUK)C29717/A17263Institute of Cancer Sciences
169638Genotype Guided Stratified Therapy for Pancreatic CancerAndrew BiankinCancer Research UK (CRUK)C29717/A18484CS -Translational Research Centre
190874CR-UK Centre renewalKaren VousdenCancer Research UK (CRUK)C596/A18076Institute of Cancer Sciences
172008Clinical Training Award Cycle 2Andrew BiankinCancer Research UK (CRUK)C596/A20921CS -Translational Research Centre
301364COMBINATION THERAPIES TARGETING IMMUNE EVASION IN PANCREATIC CANCERNigel JamiesonCancer Research UK (CRUK)C55370/A25813CS -Translational Research Centre